The condition is usually preceded by a premalignant point out (MBL) which shares most molecular drivers with overt CLL. In several cases, these molecular drivers continue being frequent with time. Having said that, clonal evolution can also be achievable and is often related to exponential tumor advancement, progressive disease and, occasionally, d